ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 33 filers reported holding ELEVATION ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $29,700 | +25069.5% | 11,000 | +47726.1% | 0.00% | – |
| Q1 2024 | $118 | -98.5% | 23 | -99.8% | 0.00% | – |
| Q4 2023 | $8,071 | -23.0% | 15,030 | -5.0% | 0.00% | – |
| Q3 2023 | $10,486 | +6798.7% | 15,816 | +15716.0% | 0.00% | – |
| Q2 2023 | $152 | +15100.0% | 100 | -88.1% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 842 | -87.9% | 0.00% | – |
| Q3 2022 | $8,000 | 0.0% | 6,967 | +29.5% | 0.00% | – |
| Q2 2022 | $8,000 | +60.0% | 5,382 | +161.9% | 0.00% | – |
| Q1 2022 | $5,000 | -16.7% | 2,055 | +106.5% | 0.00% | – |
| Q4 2021 | $6,000 | – | 995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 2,834,910 | $7,654,257 | 3.31% |
| venBio Partners LLC | 2,434,255 | $6,572,489 | 2.84% |
| Velan Capital Investment Management LP | 597,299 | $1,612,707 | 0.92% |
| Exome Asset Management LLC | 369,322 | $997,170 | 0.87% |
| Logos Global Management LP | 3,850,000 | $10,395,000 | 0.84% |
| TANG CAPITAL MANAGEMENT LLC | 3,060,000 | $8,262,000 | 0.84% |
| Palo Alto Investors LP | 1,800,106 | $4,860,286 | 0.56% |
| Darwin Global Management, Ltd. | 1,916,290 | $4,809,888 | 0.56% |
| Ghost Tree Capital, LLC | 600,000 | $1,620,000 | 0.51% |
| Affinity Asset Advisors, LLC | 1,468,825 | $3,965,828 | 0.46% |